Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesDermatomyositis and small cell carcinoma of the bladder
Canadian Family Physician, 10/14/09
Sagi L et al. – To the best of the authors' knowledge, this is the first report of an association between small cell carcinoma of the bladder (SCCB) and dermatomyositis (DM). The lack of previous such observations, as opposed to an abundance of reports connecting SCLC and DM, presumably stems from the rarity of the former tumour as opposed to the preponderance of lung carcinoma.
Related Articles
Susceptibility to urinary bladder cancer: relevance of rs9642880[T], GSTM1 0/0 and occupational exposure
Pharmacogenetics and genomics, 10/30/09
Relevance Score: 81%
Increased bladder cancer risk among workers exposed to o-toluidine and aniline: A reanalysis
Occupational and Environmental Medicine, 11/06/09
Relevance Score: 79%
Diagnosis and Treatment of Bladder Cancer
American Family Physician, 10/01/09
Relevance Score: 79%
Sequence Variant on 3q28 and Urinary Bladder Cancer Risk: Findings from the Los Angeles-Shanghai Bladder Case-Control Study
Cancer Epidemiology, Biomarkers & Prevention, 10/27/09
Relevance Score: 69%
Fat Within the Wall of the Urinary Bladder: Computed Tomographic Appearance
Journal of Computer Assisted Tomography, 10/12/09
Relevance Score: 69%
Today in Bladder...keeping you current
Receive free subspecialty "5-minute updates" via email
A MicroRNA expression profile defining the invasive bladder tumor phenotype
Urologic Oncology: Seminars and Original Investigations, 12/18/09
Combination of vesicoureteric reflux and vesicoureteric junction obstruction
Scandinavian Journal of Urology and Nephrology, 12/18/09
Behavioral Intervention versus Pharmacotherapy or Their Combinations in the Management of Overactive Bladder Dysfunction
Advances in Urology, 12/18/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
High DNA Methyltransferase 3B Expression Mediates 5-Aza-Deoxycytidine Hypersensitivity in Testicular Germ Cell Tumors
Cancer Research, 12/18/09
Phase I trial with a combination of docetaxel and 153Sm-lexidronam in patients with castration-resistant metastatic prostate cancer
Urologic Oncology: Seminars and Original Investigations, 12/18/09
Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer
Clinical Cancer Research, 12/18/09
Article Search
Sponsor